Status:

TERMINATED

Study to Evaluate the Efficacy and Safety of CC-90001 in Participants With Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis

Lead Sponsor:

Celgene

Conditions:

Non-alcoholic Fatty Liver Disease

Liver Cirrhosis

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

This is a Phase 2, randomized, double-blind, placebo-controlled, multicenter, multinational, dose-finding study evaluating the efficacy of three treatment doses of CC-90001 compared with placebo, in N...

Eligibility Criteria

Inclusion

  • Key Inclusion Criteria Diagnosis of non-alcoholic steatohepatitis (NASH) with presence of Stage 2, Stage 3 fibrosis based of the non-alcoholic steatohepatitis (NASH) Clinical Research Network (CRN) Histologic Scoring System and a nonalcoholic fatty liver disease (NAFLD) Activity Score (NAS) of 4 or higher

Exclusion

  • \- Key Exclusion Criteria
  • History or evidence of decompensated liver disease,
  • Hepatitis and fibrosis more likely related to etiologies other than non-alcoholic steatohepatitis (NASH).
  • Participant has urine ethyl glucuronide (EtG) \> 500 ng/mL at Screening.
  • History or positive screen for human immunodeficiency virus (HIV) infection or congenital or human immunodeficiency virus (HIV)-unrelated acquired immunodeficiencies (eg, common variable immunodeficiency \[CVID\]).
  • History of hepatitis B and/or hepatitis C.
  • History of malignancy within the last 5 years (exceptions: excised and cured basal/squamous cell skin carcinomas and cervical carcinoma in situ).
  • Pregnancy or lactation.

Key Trial Info

Start Date :

August 14 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 28 2021

Estimated Enrollment :

56 Patients enrolled

Trial Details

Trial ID

NCT04048876

Start Date

August 14 2019

End Date

September 28 2021

Last Update

June 7 2023

Active Locations (142)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 36 (142 locations)

1

Saint Joseph's Hosptial and Medical Center - Barrow Neurological Institute

Phoenix, Arizona, United States, 85013

2

Mayo Clinic Phoenix

Phoenix, Arizona, United States, 85054

3

UC San Diego School of Medicine

La Jolla, California, United States, 92093-0960

4

Cedars-Sinai Comprehensive Transplant Center

Los Angeles, California, United States, 90048